News
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
Bone growth occurs through the proliferation of specialized cells of the cartilage tissue, known as chondrocytes, on either end of a bone. This process requires the synthesis of extracellular matrix ...
Hosted on MSN29d
PDE3 inhibitors show promise in promoting bone growthOf particular interest in this entire signaling pathway is an enzyme called phosphodiesterase ... promote skeletal bone growth. PDE3 inhibitors are already in clinical use for treating heart failure, ...
The use of isoenzyme-selective phosphodiesterase (PDE) inhibitors is considered a great opportunity to treat various diseases of the human urogenital tract.
Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the ...
Stepping down to as-needed ICS/FABA maintained asthma stability while significantly reducing steroid exposure in individuals ...
Learn more about the interesting connections between the brain and heart culminating in mast cell activation and development of Kounis syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results